- Home
- CRGO vs PLX Comparison
CRGO vs PLX Comparison
Compare CRGO & PLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CRGO | PLX |
|---|---|---|
| Founded | 2012 | 1993 |
| Country | Spain | United States |
| Employees | N/A | N/A |
| Industry | Blank Checks | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 195.4M | 230.0M |
| IPO Year | N/A | 1996 |
Fundamental Metrics
Financial Performance| Metric | CRGO | PLX |
|---|---|---|
| Price | $1.68 | $2.15 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $12.00 |
| AVG Volume (30 Days) | 236.1K | ★ 1.1M |
| Earning Date | 02-23-2026 | 03-18-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $52,744,000.00 |
| Revenue This Year | $10.61 | $37.52 |
| Revenue Next Year | $16.85 | $1.25 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $1.17 | $1.34 |
| 52 Week High | $4.24 | $3.19 |
Technical Indicators
Market Signals| Indicator | CRGO | PLX |
|---|---|---|
| Relative Strength Index (RSI) | 53.47 | 32.33 |
| Support Level | $1.17 | $2.03 |
| Resistance Level | $2.51 | $2.45 |
| Average True Range (ATR) | 0.14 | 0.13 |
| MACD | 0.07 | -0.11 |
| Stochastic Oscillator | 80.97 | 8.23 |
Price Performance
Historical ComparisonAbout CRGO Freightos Limited Ordinary shares
Freightos Ltd operates as a vendor-neutral booking and payment platform for international freight. Its platform supports supply chain efficiency and agility by enabling real-time procurement of ocean and air shipping across more than ten thousand importers/exporters. forwarders, and dozens of airlines and ocean carriers. WebCargo by Freightos is a freight platform connecting carriers and forwarders in particular an air cargo eBooking platform. Freightos.com is a digital international freight marketplace for importers and exporters for instant pricing, booking, and shipment management. The company operates in two segments-Platform segment and Solutions segment. Geographically, the company operates in Europe, Hong Kong, United States which is majority revenue generator and others.
About PLX Protalix BioTherapeutics Inc. (DE)
Protalix BioTherapeutics Inc is a biopharmaceutical company focused on the development and commercialization of recombinant therapeutic proteins based on its proprietary ProCellEx protein expression system or ProCellEx. It has developed taliglucerase alfa for the treatment of Gaucher disease. The company's products also treat diseases like Fabry disease and cystic fibrosis. The company's primary sources of revenue include its sales of BioManguinhos alfataliglicerase in Brazil and of drug substances to Pfizer under its Amended Pfizer Agreement. The company's pipeline consists of ELFABRIO, Uricase, and Long Acting DNase I.